Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yida Li

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|March 14, 2022
Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?Li Chu, Shuai Liu, Tiantian Guo, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapyJinmeng Zhang, Jie Gao, Shanshan Jiang, et al.
ACS Omega|November 21, 2022
All Solution-Processed Inorganic, Multilevel Memristors Utilizing Liquid Metals Electrodes Suitable for Analog ComputingMuhammad Zaheer, Aziz-Ur-Rahim Bacha, Iqra Nabi, et al.
International Journal of Cancer|December 16, 2021
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasisYang Zhao, Shuyan Li, Xi Yang, et al.
International Journal of Biological Sciences|January 12, 2026
Extracellular vesicles derived from irradiated tumor cells foster immunosuppressive macrophages formation to promote esophageal squamous cell carcinoma immune evasionShanshan Jiang, Yechun Pang, Yue Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2023
Spontaneous Threshold Lowering Neuron using Second-Order Diffusive Memristor for Self-Adaptive Spatial AttentionYang Jiang, Dingchen Wang, Ning Lin, et al.
Cell Reports. Medicine|July 29, 2025
Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancerLili Huang, Weiqing Lu, Ruiyan Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2021
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain MetastasesFan Yu, Jianjiao Ni, Wanqin Zeng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitorsYue Zhou, Bo Wang, Jinghan Qu, et al.
Translational Lung Cancer Research|March 14, 2022
Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitorsTiantian Guo, Li Chu, Xiao Chu, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|March 14, 2022
Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?Li Chu, Shuai Liu, Tiantian Guo, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapyJinmeng Zhang, Jie Gao, Shanshan Jiang, et al.
ACS Omega|November 21, 2022
All Solution-Processed Inorganic, Multilevel Memristors Utilizing Liquid Metals Electrodes Suitable for Analog ComputingMuhammad Zaheer, Aziz-Ur-Rahim Bacha, Iqra Nabi, et al.
International Journal of Cancer|December 16, 2021
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasisYang Zhao, Shuyan Li, Xi Yang, et al.
International Journal of Biological Sciences|January 12, 2026
Extracellular vesicles derived from irradiated tumor cells foster immunosuppressive macrophages formation to promote esophageal squamous cell carcinoma immune evasionShanshan Jiang, Yechun Pang, Yue Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2023
Spontaneous Threshold Lowering Neuron using Second-Order Diffusive Memristor for Self-Adaptive Spatial AttentionYang Jiang, Dingchen Wang, Ning Lin, et al.
Cell Reports. Medicine|July 29, 2025
Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancerLili Huang, Weiqing Lu, Ruiyan Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2021
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain MetastasesFan Yu, Jianjiao Ni, Wanqin Zeng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitorsYue Zhou, Bo Wang, Jinghan Qu, et al.
Translational Lung Cancer Research|March 14, 2022
Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitorsTiantian Guo, Li Chu, Xiao Chu, et al.
Pageof 8